5 completed. 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Anders Kvanta: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen Aflibercept, Ranibizumab - Central Retinal Vein Occlusion | Phase 4 | Completed | Anders Kvanta | 40 | 2014-10-01 | 2020-12-04 |
| Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy Intravitreal dexamethasone implant, Vitrectomy - Proliferative Diabetic Retinopathy | Phase 2 | Completed | Anders Kvanta | 100 | 2011-11-01 | 2024-01-30 |
| Vitrous Analysis in Proliferative Diabetic Retinopathy Proliferative Diabetic Retinopathy | Completed | Anders Kvanta | 200 | 2011-01-01 | 2014-09-25 | |
| Bevacizumab for Central Retinal Vein Occlusion Study bevacizumab, Sham bevacizumab injection - Central Retinal Vein Occlusion | Phase 3 | Completed | Anders Kvanta | 60 | 2009-05-01 | 2011-11-22 |
| The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study ranibizumab, TTT, Sham TTT - Neovascular Age-related Macular Degeneration | Phase 3 | Completed | Anders Kvanta | 100 | 2008-02-01 | 2011-11-22 |
Retinal Vein Occlusion (2) · Macular Degeneration (1) · Macular Edema (1) · Vitreous Hemorrhage (1)
Ranibizumab (2) · Bevacizumab (1) · Calcium Dobesilate (1) · Dexamethasone (1) · Vitrectomy (1) · aflibercept (1)
Sweden (5)
Sofie Westman (1)